Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18813178 | 1.00 | CTSA (1.00) | CTSA | |
| SCHEMBL16109146 | 1.00 | CTSA (1.00) | CTSA | |
| SCHEMBL18813430 | 0.92 | CTSA (1.00) | CTSA | |
| SCHEMBL18813224 | 0.88 | CTSA (1.00) | CTSA | |
| SCHEMBL18813366 | 0.88 | CTSA (1.00) | CTSA | |
| SCHEMBL18813219 | 0.88 | CTSA (1.00) | CTSA | |
| SCHEMBL18813250 | 0.87 | CTSA (1.00) | CTSA | |
| SCHEMBL18813320 | 0.87 | CTSA (1.00) | CTSA | |
| SCHEMBL18813252 | 0.87 | CTSA (1.00) | CTSA | |
| SCHEMBL18813337 | 0.86 | CTSA (1.00) | CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2978754-B1 | BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2017-05-10 | — | — | EP | claimed |
| EP-2978754-A1 | BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2016-02-03 | — | — | EP | claimed |
| US-9150526-B2 | Biaryl-propionic acid derivatives and their use as pharmaceuticals | SANOFI (FR) | 2015-10-06 | — | — | US | claimed |
| US-20140296296-A1 | Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals | SANOFI (FR) | 2014-10-02 | — | — | US | claimed |
| WO-2014154726-A1 | BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2014-10-02 | — | — | WO | claimed |
| EP-2978754-B1 | BIARYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2017-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296296-A1 | Biaryl-Propionic Acid Derivatives and their Use as Pharmaceuticals | CTSV, F2R, CTSF | CTSA 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.